Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Announces 1-for-9 Reverse Share Split to Maintain Nasdaq Listing

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.493
Mkt Cap
$2.415M
52W Low
$0.488
52W High
$10.815
Market data snapshot near publication time

summarizeSummary

SciSparc Ltd. announced a 1-for-9 reverse share split, effective March 4, 2026, to increase its per-share price and maintain compliance with Nasdaq listing requirements.


check_boxKey Events

  • Reverse Share Split Announced

    SciSparc Ltd. will effect a 1-for-9 reverse share split of its ordinary shares, effective at market open on March 4, 2026.

  • Nasdaq Compliance Focus

    The reverse split is intended to increase the per-share price to meet Nasdaq Capital Market's minimum bid price requirement, as the stock is currently trading near its 52-week low.

  • Share Count Reduction

    The number of issued and outstanding ordinary shares will be reduced from approximately 5,089,501 to approximately 565,500 post-split.

  • Impact on Warrants and Options

    A proportionate adjustment will be made to the exercise price and number of shares issuable upon exercise of all outstanding options and warrants.


auto_awesomeAnalysis

SciSparc Ltd. is implementing a 1-for-9 reverse share split, effective March 4, 2026. This action is a critical step for the company, which is currently trading near its 52-week low of $0.4881, to regain compliance with Nasdaq's minimum bid price requirement. While reverse splits are often necessary to avoid delisting, they are generally viewed negatively by the market as they can signal underlying financial distress and often lead to further share price depreciation post-split. The company has a history of highly dilutive financing activities, including recent convertible notes and shelf registrations, which are contingent on maintaining its exchange listing. This move is a desperate measure to ensure continued access to capital markets.

At the time of this filing, SPRC was trading at $0.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.49 to $10.82. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SPRC - Latest Insights

SPRC
Apr 29, 2026, 4:20 PM EDT
Filing Type: 20-F
Importance Score:
9
SPRC
Mar 16, 2026, 8:21 AM EDT
Source: Reuters
Importance Score:
7
SPRC
Mar 12, 2026, 4:41 PM EDT
Filing Type: 6-K
Importance Score:
8
SPRC
Mar 12, 2026, 7:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
SPRC
Mar 10, 2026, 9:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
SPRC
Mar 02, 2026, 8:08 AM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 17, 2026, 5:27 PM EST
Filing Type: F-3
Importance Score:
9
SPRC
Feb 17, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 12, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 03, 2026, 4:36 PM EST
Filing Type: F-3
Importance Score:
9